glp 1 birth defects Impact of semaglutide exposure on fetal and neonatal outcomes in pregnant women: a systematic review glp 1 while trying to

3.2 Second-generation long-acting analogs The evolution developed with the emergence of second-generation GLP-1 receptor agonists, suggesting a notable advancement in molecular design and clinical application

Fourthly, GLP-1 protects cardiomyocytes from oxidative stress and apoptosis in diabetes mellitus, through the mTOR complex1/p70 ribosomal protein S6 kinase (p70S6K) pathway [160]

Some people experience digestive side effects when using GLP-1 agonists, such as nausea, vomiting, diarrhea, feelings of early fullness, reduced appetite, and abdominal cramps

However, as with all pharmaceutical interventions, they are associated with a range of side effects

Eder, L., Thavaneswaran, A., Chandran, V., Cook, R